Duloxetine HCL DR Capsules
SAM.GOV Due: June 4, 2025 at 07:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The opportunity for Duloxetine HCL DR Capsules is a combined synopsis/solicitation issued by the Defense Logistics Agency (DLA) under solicitation number SPE2D2-25-R-0010. This procurement is aimed at acquiring Duloxetine HCL DR Capsules, which are used for various medical treatments. Contractors with experience in pharmaceutical manufacturing and supply, particularly those who can meet the specific regulatory and quality standards required for government contracts, are encouraged to bid. The solicitation outlines the necessary compliance with federal acquisition regulations and emphasizes the importance of timely delivery and adherence to contract specifications. Interested businesses should be prepared to demonstrate their capability to fulfill the contract requirements effectively and efficiently.
Description

SPE2D2-25-R-0010 Duloxetine HCL DR Solicitation

Entities
DOD
Department of Defense
DLA
Defense Logistics Agency
NAICS
325412
Set Aside
None
Place of Performance
Point of Contact
Full Name Email Phone Type
Christopher Newman [email protected] 4457377371 primary
Jason Wray [email protected] 4457376304 secondary
Attachments
  • Duloxetine+HCL+DR+SPE2D225R0010+Solicitation+release.pdf